Ingmar Bruns
Keine laufenden Positionen mehr
Karriereverlauf von Ingmar Bruns
Ehemalige bekannte Positionen von Ingmar Bruns
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| TRILLIUM THERAPEUTICS | Technik-/Wissenschafts-/F&E-Leiter | 02.11.2020 | 17.11.2021 |
| PIERIS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 12.10.2017 | - |
Ausbildung von Ingmar Bruns
| Universität zu Lübeck | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 2 |
| Deutschland | 2 |
| Kanada | 2 |
Operativ
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| PIERIS PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Trillium Therapeutics ULC
 Trillium Therapeutics ULC BiotechnologyHealth Technology Trillium Therapeutics, Inc. is a clinical stage immuno-oncology company, which engages in the research and development of therapies for the treatment of cancer. It offers clinical programs, TTI-621 and TTI-622, target CD47, a signal that cancer cells frequently use to evade the immune system. The company was founded on March 31, 2004 and is headquartered in Mississauga, Canada. | Health Technology |
- Börse
- Insiders
- Ingmar Bruns
- Erfahrung
